Drug intelligence / Profile preview

umbilical cord mesenchymal stem cells (Chinese PLA General Hospital, 1e96f3)

Development stage
Unknown
Lead developer
Chinese PLA General Hospital
Modality
Stem Cell Therapies → Cell Therapies
Administration
Topical, Intravenous
01

Overview

This investigational cell therapy, developed by the Chinese PLA General Hospital, utilizes human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) for the treatment of severe burns and large-area skin wounds. The therapy aims to accelerate wound healing, promote the regeneration of skin appendages such as sweat glands, and reduce systemic inflammatory complications. hUC-MSCs function primarily through paracrine mechanisms, secreting anti-inflammatory factors like TNF-alpha-induced protein 6 (TSG-6) and pro-angiogenic factors like vascular endothelial growth factor (VEGF). These cells modulate the immune response, reduce oxidative stress, and provide a supportive microenvironment for tissue repair. Clinical trials have evaluated their safety and efficacy when administered topically or in combination with skin grafts.

Other names
hUC-MSCshuman umbilical cord mesenchymal stem cells

Beyond the preview

Go deeper on umbilical cord mesenchymal stem cells (Chinese PLA General Hospital, 1e96f3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord mesenchymal stem cells (Chinese PLA General Hospital, 1e96f3).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call